Will V940 get approval from the FDA for lung cancer?
3
Ṁ70Ṁ482030
71%
chance
1H
6H
1D
1W
1M
ALL
V940-002 is a personalized cancer vaccine (Moderna) + pembrolizumab (Merck). The trial (link) is on patients with resected non small cell lung cancer. Will it pass phase 3 and get approval?
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
45% chance
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
21% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
26% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against esophageal adenocarcinoma before 2028?
33% chance
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Will FDA approve any mRNA vaccine against pancreatic adenocarcinoma before 2028?
19% chance
Will Lantern Bioworks Lumina treatment be FDA Approved for preventing tooth decay by the end of 2026?
3% chance
Will FDA approve any mRNA vaccine against stomach adenocarcinoma before 2028?
30% chance
Will AOH1996 be FDA approved before 2040?
40% chance